Reports
Global Apheresis Market Share, Report, Forecast: By Product: Devices, Disposables; By Technology: Centrifugation, Membrane Separation; By Procedure: Plasmapheresis, Leukapheresis, Erythrocytapheresis, Plateletpheresis, Others; By Application: Renal Disease, Others; By End User; Regional Analysis; Supplier Landscape; 2023-2031
Global Apheresis Market Outlook
The global apheresis market size was about USD 2.45 billion in 2022, driven by the growing demand for blood components for transfusion across the globe. The market share is anticipated to grow at a CAGR of 9.2% during the forecast period of 2023-2031 to achieve a value of USD 5.40 billion by 2031.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America Accounts for a Significant Share in the Global Apheresis Industry
North America is one of the leading regions in the global apheresis industry. The development of this market in North America has been driven by the growing technological advancements, increased opportunities for apheresis drugs, and the prevalence of a large number of people suffering from various chronic diseases. Another significant market for the product is Europe, which is followed by the Asia Pacific. Meanwhile, the Asia Pacific is expected to witness a healthy growth in the forecast period. The Asia Pacific apheresis industry is growing due to the rising demand for various blood components for patients, rapid advancements in the region’s healthcare system, and rising healthcare spending. Furthermore, the rising prevalence of leukaemia has been one of the major reasons for the growth of the market.
Apheresis: Market Segmentation
Apheresis is a surgical technique that requires taking a donor's or a patient's entire blood and splitting it into different components so that one component can be extracted. The leftover blood products are first reintroduced into the patient's or donor's bloodstream. The separation of the component involves two processes namely centrifugation and filtration.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The apheresis industry can be categorised by product into:
- Devices
- Disposables
The various technologies associated with apheresis include:
- Centrifugation
- Membrane Separation
The classification of apheresis according to the procedure is as follows:
- Plasmapheresis
- Leukapheresis
- Erythrocytapheresis
- Plateletpheresis
- Others
The applications of apheresis are as follows:
- Renal diseases
- Haematological diseases
- Autoimmune diseases
- Neurological diseases
- Others
The regional markets for apheresis can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increased Demand for Blood Components Bolstering the Apheresis Industry Growth
The increase in demand for blood components across the world and the increased government efforts to encourage blood donation are the major factors driving the global apheresis industry forward. Acute disseminated encephalomyelitis, autoimmune haemolytic anaemia, and cardiac neonatal lupus are among the latest apheresis signs that have recently been authorised. The growing demand for various blood components, the complexity of surgical operations, and an increase in the number of injuries around the world have all led to the market's expansion. The lack of qualified practitioners and risks associated with the apheresis process, on the other hand, are likely to stifle market development. Over the forecast period, the increased demand for plasma-derived pharmaceuticals is expected to present lucrative prospects for business growth.
Key Industry Players in the Global Apheresis Market
The report gives a detailed analysis of the following key players in the global apheresis market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Nikkiso Co., Ltd.
- Asahi Kasei Medical Co. Ltd
- B. Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Terumo Bct, Inc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2016-2022 |
| Forecast Period | 2023-2031 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Technology |
|
| Breakup by Procedure |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Apheresis Market Overview
3.1 Global Apheresis Market Historical Value (2016-2022)
3.2 Global Apheresis Market Forecast Value (2023-2031)
4 Global Apheresis Market Landscape
4.1 Global Apheresis Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Apheresis Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End User
5 Global Apheresis Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Apheresis Market Segmentation
6.1 Global Apheresis Market by Product
6.1.1 Market Overview
6.1.2 Devices
6.1.3 Disposables
6.2 Global Apheresis Market by Technology
6.2.1 Market Overview
6.2.2 Centrifugation
6.2.3 Membrane Separation
6.3 Global Apheresis Market by Procedure
6.3.1 Market Overview
6.3.2 Plasmapheresis
6.3.3 Leukapheresis
6.3.4 Erythrocytapheresis
6.3.5 Plateletpheresis
6.3.6 Others
6.4 Global Apheresis Market by Application
6.4.1 Market Overview
6.4.2 Renal Disease
6.4.3 Hematological Disease
6.4.4 Autoimmune Disease
6.4.5 Neurological Disease
6.4.6 Others
6.5 Global Apheresis Market by End User
6.5.1 Market Overview
6.5.2 Blood Collection Centers and Blood Component Providers
6.5.3 Hospitals and Transfusion Centers
6.5.4 Others
6.6 Global Apheresis Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Apheresis Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Apheresis Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Apheresis Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Apheresis Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Apheresis Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Nikkiso Co., Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Asahi Kasei Medical Co. Ltd
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 B. Braun Melsungen AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Fresenius SE & Co. KGaA
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Terumo Bct, Inc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Haemonetics Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Mallinckrodt
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Kaneka Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Kawasumi Laboratories, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Miltenyi Biotec
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Infomed
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Toray Medical Co., Ltd.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Apheresis Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
Theglobal market for apheresis was valued at USD 2.45 billion in 2022.
The market is expected to grow at a CAGR of 9.2% during the forecast period of 2023-2031 to reach a value of USD 5.40 billion by 2031.
The major drivers of the industry include growing demand for various blood components, the complexity of surgical operations, and an increase in the number of injuries.
The increase in demand for blood components across the world and the increased government efforts to encourage blood donation are expected to be key trends guiding the growth of the industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The components of apheresis available are devices and disposables.
Apheresis finds applications in renal diseases, haematological diseases, autoimmune diseases, and neurological diseases, among others.
Based on technology, the industry can be divided into centrifugation and membrane separation.
The procedure for apheresis include plasmapheresis, leukaepheresis, erythrocytapheresis and plateletpheresis, amongst others.
The leading players in this market are Nikkiso Co., Ltd., Asahi Kasei Medical Co. Ltd, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Terumo Bct, Inc, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$3499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$5999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$7999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$9999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER